Palo Alto Networks, Inc. (NYSE: PANW) — FY2021 Form 10-K
Reporting period: Fiscal year ended July 31, 2021. This is an annual filing, not a standalone fourth-quarter report. Amounts are in U.S. dollars.
Business context
Palo Alto Networks provides cybersecurity products and services spanning next-generation firewalls, cloud security, secure access service edge (SASE), security analytics and automation, and Unit 42 threat intelligence and consulting. Sales are primarily made through distributors and resellers. Subscription and support contracts are generally one to five years, with revenue recognized over the service period.
Financial performance
| Metric | FY2021 | FY2020 |
|---|---|---|
| Revenue | $4.256 billion | $3.408 billion |
| Product revenue | $1.120 billion; +5.3% | $1.064 billion |
| Subscription and support revenue | $3.136 billion; +33.8% | $2.344 billion |
| Gross margin | 70.0% | 70.7% |
| Operating loss | $304.1 million | $179.0 million |
| Net loss | $498.9 million | $267.0 million |
| Net loss per share, diluted | $5.18 | $2.76 |
| Billings | $5.452 billion; +26.7% | $4.302 billion |
| Cash from operations | $1.503 billion | $1.036 billion |
| Free cash flow, non-GAAP | $1.387 billion | $821.3 million |
| Cash, cash equivalents and investments | $3.789 billion | $4.302 billion |
| Total deferred revenue | $5.024 billion | $3.810 billion |
Subscription and support provided 73.7% of FY2021 revenue, up from 68.8%. Product gross margin was 72.5%, while subscription and support gross margin was 69.2%; the latter fell from 69.9%, primarily due to higher professional-services fulfillment costs. Operating expenses rose to $3.285 billion from $2.588 billion, led by a 48.5% increase in research and development spending. Share-based compensation was $926.9 million, versus $664.5 million.
Liquidity, debt and capital allocation
- Cash, cash equivalents and investments totaled $3.789 billion at year-end, including $942.3 million held outside the United States. Working capital was negative $469.4 million, compared with positive $2.438 billion a year earlier; the filing attributes current classification of the 2023 convertible notes to their conversion eligibility.
- Convertible notes had $3.692 billion aggregate principal outstanding: $1.692 billion due 2023 and $2.000 billion due 2025. The 2023 notes became convertible during the quarter ending October 31, 2021. Their $1.558 billion net carrying amount was classified as current at July 31, 2021. The company said operating cash flow and existing cash and investments were sufficient for anticipated needs if holders converted.
- No borrowings were outstanding under the $400 million revolving credit facility; the company reported covenant compliance.
- Operating cash flow improved, while investing activities used $1.481 billion, primarily reflecting investment purchases and acquisitions. Financing activities used $1.104 billion, including $1.178 billion of share repurchases.
- At July 31, $323.9 million remained under the then-current repurchase authorization. A subsequent August 17, 2021 authorization increase brought remaining authorization to $1.0 billion, with expiration extended to December 31, 2022.
Material changes and notable items
- Revenue grew 24.9%, compared with 17.5% in FY2020; subscription and support growth substantially exceeded product growth.
- Net loss widened to $498.9 million from $267.0 million, and operating loss widened to $304.1 million from $179.0 million. The filing cites increased operating expenses, including investment in R&D and personnel, alongside revenue growth.
- Four acquisitions were completed in FY2021: Crypsis, Sinefa, Expanse and Bridgecrew. Expanse purchase consideration was $797.2 million, including cash, stock and replacement awards. Total goodwill rose to $2.710 billion from $1.813 billion, largely reflecting acquisitions.
- The company repurchased and retired 4.0 million shares for $1.2 billion during FY2021. Outstanding common shares were 97.3 million at year-end, versus 96.3 million a year earlier.
- Remaining performance obligations were $5.9 billion at year-end; the company expected to recognize approximately $3.1 billion over the next 12 months.
- Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting. Revenue recognition and the Expanse acquisition valuation were identified as critical audit matters.
Outlook, risks and contingencies
Management expects continued investment in research and development, sales capacity, customer support and cloud-based offerings. The filing does not provide a clear numerical FY2022 revenue or earnings guidance figure. Management stated that cash from operations and existing cash and cash equivalents should meet anticipated needs for at least the next 12 months and thereafter for the foreseeable future.
- COVID-19 and economic uncertainty could delay purchases, lengthen sales cycles and payment terms, and constrain customers’ or partners’ ability to pay. The full financial impact could not be reasonably estimated.
- The company reported supply-chain exposure, including reliance on manufacturing partners and limited-source components, and cited COVID-19-related disruption, semiconductor shortages and increased freight costs.
- Distribution and receivables are concentrated: three distributors generated 56.0% of revenue; four distributors represented 56.6% of gross accounts receivable at year-end.
- Competitive pressure, pricing, customer renewals, product defects or security incidents, privacy regulation, foreign exchange, and acquisition integration are among the stated business risks.
- Contractual obligations totaled $5.950 billion, including $1.832 billion of purchase obligations, $3.692 billion of note principal and $426.6 million of operating lease payments. The filing reported approximately $80.6 million of uncertain tax liabilities outside that table.
- The company reported no significant litigation accruals and did not determine that an unfavorable litigation outcome was probable or reasonably possible as of July 31, 2021.
Key facts for investors to verify
- Whether subscription and support growth and deferred-revenue growth continue, and how renewals affect future recognized revenue.
- Whether operating-expense growth, particularly share-based compensation and R&D, moderates sufficiently to improve GAAP operating margins.
- Liquidity and cash requirements if holders convert the 2023 notes, and the potential dilution or cash impact from convertible notes and related warrants.
- Acquisition integration and returns, including the valuation and performance assumptions underlying the large Expanse goodwill and acquired intangibles.
- Exposure to distributor concentration, customer credit, semiconductor availability, and fulfillment costs.
- Use of the expanded repurchase authorization relative to cash needs, debt obligations and investment plans.